Martin, Renee' H; Yeatts, Sharon D; Hill, Michael D et al. (2016) ALIAS (Albumin in Acute Ischemic Stroke) Trials: Analysis of the Combined Data From Parts 1 and 2. Stroke 47:2355-9
|
Ginsberg, Myron D; Hill, Michael D (2015) Symptomatic intracranial hemorrhage in the ALIAS Multicenter Trial: relationship to endovascular thrombolytic therapy. Int J Stroke 10:494-500
|
Hill, Michael D; Martin, Renee H; Palesch, Yuko Y et al. (2015) Albumin Administration in Acute Ischemic Stroke: Safety Analysis of the ALIAS Part 2 Multicenter Trial. PLoS One 10:e0131390
|
Ginsberg, Myron D; Palesch, Yuko Y; Hill, Michael D et al. (2013) High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial. Lancet Neurol 12:1049-58
|
Hill, Michael D; Martin, Renee H; Palesch, Yuko Y et al. (2011) The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysis. Stroke 42:1621-5
|
Ginsberg, Myron D (2011) Visualizing the cortical microcirculation in patients with stroke. Crit Care Med 39:1228-30
|
Ginsberg, Myron D; Palesch, Yuko Y; Martin, Renee H et al. (2011) The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke 42:119-27
|
Mullen, Michael T; Pantelyat, Alexander; Pukenas, Bryan A et al. (2010) Teaching NeuroImages: occlusion of all 4 major extracranial vessels. Neurology 75:e51
|
Luchsinger, José A (2010) Insulin resistance, type 2 diabetes, and AD: cerebrovascular disease or neurodegeneration? Neurology 75:758-9
|
Kosior, Robert K; Hill, Michael D; Frayne, Richard (2010) Less could be more when it comes to diffusion imaging of acute stroke. Neurology 74:1936-7
|
Showing the most recent 10 out of 21 publications